A review of the incidence of tumor lysis syndrome in patients with chronic lymphocytic leukemia treated with venetoclax and debulking strategies

We reviewed the literature (January 2010–June 2021) on the effectiveness of debulking strategies before venetoclax initiation in patients with chronic lymphocytic leukemia to reduce tumor burden, downgrade tumor lysis syndrome (TLS) risk, and avoid hospitalization. Low TLS incidence and reduced TLS...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharman, Jeffrey P., Biondo, Juliana M. L., Boyer, Michelle, Fischer, Kirsten, Hallek, Michael, Jiang, Dingfeng, Kater, Arnon P., Porro Lurà, Michele, Wierda, William G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175963/
https://www.ncbi.nlm.nih.gov/pubmed/35846043
http://dx.doi.org/10.1002/jha2.427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175963/
https://www.ncbi.nlm.nih.gov/pubmed/35846043
http://dx.doi.org/10.1002/jha2.427

Ejemplares similares